Uploaded July 2026 | Updated September 2026, 2 weeks ago
Learn more about our upcoming in-person patients and caregivers conference here:
pcri.org/2026-conference
Learn about PSMA at pcri.org/psma
00:00 Introduction
00:37 Are there any forms of prostate cancer best left untreated?
03:35 What kinds of prostate cancer qualify for active surveillance?
05:37 How does active surveillance differ from doing nothing?
07:24 How long can active surveillance last?
08:23 Can delaying treatment also delay the chance of a cure?
09:10 Does a patient's age play into the decision to go on active surveillance?
10:20 What does "treatment" mean in the context of prostate cancer?
11:29 What developments might prompt someone to end active surveillance and start treatment?
12:49 How does genetic testing play into the procedure for active surveillance?
14:20 How can patients best frame active surveillance for their loved ones?
15:39 What proportion of men on active surveillance stay on it for a prolonged period?
16:58 Alex's conclusions
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
Learn more about our upcoming in-person patients and caregivers conference here:
pcri.org/2026-conference
Learn about PSMA at pcri.org/psma
00:00 Introduction
00:37 Are there any forms of prostate cancer best left untreated?
03:35 What kinds of prostate cancer qualify for active surveillance?
05:37 How does active surveillance differ from doing nothing?
07:24 How long can active surveillance last?
08:23 Can delaying treatment also delay the chance of a cure?
09:10 Does a patient's age play into the decision to go on active surveillance?
10:20 What does "treatment" mean in the context of prostate cancer?
11:29 What developments might prompt someone to end active surveillance and start treatment?
12:49 How does genetic testing play into the procedure for active surveillance?
14:20 How can patients best frame active surveillance for their loved ones?
15:39 What proportion of men on active surveillance stay on it for a prolonged period?
16:58 Alex's conclusions
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
